z-logo
open-access-imgOpen Access
Molecular quantification of Rifampicin-resistance in Mycobacterium tuberculosis
Author(s) -
Abdulameer A. Al-Mussawi,
Naael Hussein Ali,
Alaa H. Abed
Publication year - 2017
Publication title -
egyptian journal of chest diseases and tuberculosis/egyptian journal of chest diseases and tuberculosis
Language(s) - English
Resource type - Journals
eISSN - 2090-9950
pISSN - 0422-7638
DOI - 10.1016/j.ejcdt.2017.01.009
Subject(s) - medicine , rifampicin , mycobacterium tuberculosis , tuberculosis , microbiology and biotechnology , virology , pathology , biology
Aims and objectives: The current study was carried out to quantify drug resistance in tuberculous patients in Basra Province, south of Iraq.Methods: A total of 2246 presumptive tuberculosis patients were referred to and examined at the Advisory Clinic for Chest Diseases and Respiratory (ACCDR), the only health center that deals with this health problem in the province. Infected persons were investigated for Rifampicin resistance using GeneXpert test.Results: It has been found that about 10% of the examined presumptive patients were tuberculous. Out of those, about 7.56% were found to be Rifampicin resistant.Conclusions: The findings showed that the percentage, of Rifampicin resistance in tuberculous patients in Basrah was within the regional range of the drug resistance

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here